Welcome to LookChem.com Sign In | Join Free Post buying lead Chemical Tools
Home > Hot Product_List > Cycloleucine

Basic information

  • Name:
  • Cyclopentanecarboxylicacid, 1-amino-

  • Superlist Name:
  • Cycloleucine
  • CAS No.:
  • 52-52-8

  • Molecular Structure:
  • Formula:
  • C6H11NO2
  • Molecular Weight:
  • 129.16 .
  • Synonyms:
  • 1-Amino-1-carboxycyclopentane;1-Aminocyclopentane-1-carboxylic acid;1-Aminocyclopentanecarboxylic acid;ACPC;Cycloleucin;NSC 1026;NSC 112194;NSC 112195;NSC 112197;WR 14997;
  • EINECS:
  • 200-144-6
  • Density:
  • 1.207 g/cm3
  • Melting Point:
  • 320 °C (dec.)(lit.)
  • Boiling Point:
  • 256.1 °C at 760 mmHg
  • Flash Point:
  • 108.7 °C
  • Solubility:
  • 5 g/100 mL in waier
  • Appearance:
  • white to beige crystalline flakes or powder
  • Hazard Symbols:
  • IrritantXi, HarmfulXn
  • Risk Codes:
  • 22
  • Safety Description:
  • 22-24/25 Details
  • Transport Information:
  • UN 2811 6.1/PG 3

Famous Chemical Enterprises

  • Livzon
  • Total
  • Shell
  • Dupont
  • Exxonmobil
  • Akzonobel
  • Basf
  • Bayer
  • BP

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Consensus Reports

Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.

Specification

The IUPAC name of Cycloleucine is 1-aminocyclopentane-1-carboxylic acid. With the CAS registry number 52-52-8, it is also named as Cyclopentanecarboxylic acid, 1-amino-, L-. The product's categories are Pharmacetical; Amino Acids; Amino Acids; Amino Acids & Derivatives; Cycloalkanes, and the other registry number is 15313-85-6. Besides, it is white to beige crystalline flakes or powder, which should be stored in sealed, cool and dry place at room temperature. In addition, its molecular formula is C6H11NO2 and molecular weight is 129.16.

The other characteristics of this product can be summarized as: (1)EINECS: 200-144-6; (2)ACD/LogP: -0.05; (3)# of Rule of 5 Violations: 0; (4)ACD/LogD (pH 5.5): -2.55; (5)ACD/LogD (pH 7.4): -2.55; (6)ACD/BCF (pH 5.5): 1; (7)ACD/BCF (pH 7.4): 1; (8)ACD/KOC (pH 5.5): 1; (9)ACD/KOC (pH 7.4): 1; (10)#H bond acceptors: 3; (11)#H bond donors: 3; (12)#Freely Rotating Bonds: 2; (13)Index of Refraction: 1.522; (14)Molar Refractivity: 32.62 cm3; (15)Molar Volume: 106.9 cm3; (16)Surface Tension: 53.2 dyne/cm; (17)Density: 1.207 g/cm3; (18)Flash Point: 108.7 °C; (19)Melting point: 320 °C; (20)Water solubility: 5 g/100 mL; (21)Enthalpy of Vaporization: 54.35 kJ/mol; (22)Boiling Point: 256.1 °C at 760 mmHg; (23)Vapour Pressure: 0.00481 mmHg at 25 °C.

Preparation of Cycloleucine: this chemical can be prepared by 1,3-Diaza-spiro[4.4]nonane-2,4-dione.



This reaction needs 3 N aq. NaOH by heating. The yield is 75 %.

Uses of Cycloleucine:  this chemical is a non-metabolisable amino acid. It is a specific and reversible inhibitor of nucleic acid methylation. It is widely used in biochemical experiments. Additionally, it can react with Ethanol to get 1-Amino-cyclopentanecarboxylic acid ethyl ester.



This reaction needs HCl. The yield is 86.5 %.

When you are using this chemical, please be cautious about it as the following: it is harmful if swallowed. Please do not breathe dust. And you should avoid contact with skin and eyes.

People can use the following data to convert to the molecule structure.
(1)SMILES: O=C(O)C1(N)CCCC1
(2)InChI: InChI=1/C6H11NO2/c7-6(5(8)9)3-1-2-4-6/h1-4,7H2,(H,8,9)
(3)InChIKey: NILQLFBWTXNUOE-UHFFFAOYAN
(4)Std. InChI: InChI=1S/C6H11NO2/c7-6(5(8)9)3-1-2-4-6/h1-4,7H2,(H,8,9)
(5)Std. InChIKey: NILQLFBWTXNUOE-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LDLo intravenous 4gm/kg (4000mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 469, 1971.
dog LD50 intravenous 300mg/kg (300mg/kg)   Journal of Medicinal and Pharmaceutical Chemistry. Vol. 3, Pg. 1, 1961.
dog LD50 oral 300mg/kg (300mg/kg)   Journal of Medicinal and Pharmaceutical Chemistry. Vol. 3, Pg. 1, 1961.
guinea pig LD50 oral 140mg/kg (140mg/kg)   Journal of Medicinal and Pharmaceutical Chemistry. Vol. 3, Pg. 1, 1961.
human TDLo oral 60mg/kg (60mg/kg) BEHAVIORAL: ANOREXIA (HUMAN

GASTROINTESTINAL: NAUSEA OR VOMITING
Journal of Medicinal and Pharmaceutical Chemistry. Vol. 3, Pg. 1, 1961.
mouse LD50 intraperitoneal 119mg/kg (119mg/kg)   National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986,
mouse LD50 oral 309mg/kg (309mg/kg)   Journal of Medicinal and Pharmaceutical Chemistry. Vol. 3, Pg. 1, 1961.
mouse LD50 subcutaneous 375mg/kg (375mg/kg)   National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986,
quail LD50 oral > 316mg/kg (316mg/kg)   Ecotoxicology and Environmental Safety. Vol. 6, Pg. 149, 1982.
rat LD50 intravenous 340mg/kg (340mg/kg)   Journal of Medicinal and Pharmaceutical Chemistry. Vol. 3, Pg. 1, 1961.
rat LD50 oral 290mg/kg (290mg/kg)   Journal of Medicinal and Pharmaceutical Chemistry. Vol. 3, Pg. 1, 1961.
 

Please post your buying leads
so that our qualified suppliers will soon contact you!

©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

[Hangzhou]86-571-85317600,85317603,85317620